Kineta

1 follower


Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.

Industries

+1

Headquarters

Stage

Employees

Links

Shawn Iadonato

Collapse
Craig Philips
President
Thierry Guillaudeux
Chief Scientific Officer
Pauline Kenny
General Counsel